Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Leriglitazone (hydrochloride)

Product Specifications

Product Name Alternative

BAY-N-7133

UNSPSC Description

Leriglitazone (MIN-102; Hydroxypioglitazone) hydrochloride is an orally active and a BBB-penatrable PPARγ agonist with an EC50 of 9 μM. Leriglitazone hydrochloride, as a regulator of mitochondrial function, has neuroprotective, anti-inflammatory and antioxidant effects. Leriglitazone hydrochloride can be used in the study of neuroinflammatory and neurodegenerative diseases[1][2][3][4].

Target Antigen

PPAR

Type

Reference compound

Related Pathways

Cell Cycle/DNA Damage;Metabolic Enzyme/Protease;Vitamin D Related/Nuclear Receptor

Field of Research

Metabolic Disease; Inflammation/Immunology; Neurological Disease

Assay Protocol

https://www.medchemexpress.com/leriglitazone-hydrochloride.html

Purity

99.64

Solubility

DMSO : 50 mg/mL (ultrasonic)

Smiles

O=C(N1)SC(CC2=CC=C(OCCC3=NC=C(C(O)C)C=C3)C=C2)C1=O.[H]Cl

Molecular Weight

408.90

References & Citations

[1]Santambrogio P, et al PPAR Gamma Agonist Leriglitazone Recovers Alterations Due to Pank2-Deficiency in hiPS-Derived Astrocytes. Pharmaceutics. 2023 Jan 6;15(1):202. |[2]Rodríguez-Pascau L, et al. PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia. Neurobiol Dis. 2021 Jan;148:105162.|[3]Musokhranova U, et al. Mitochondrial modulation with leriglitazone as a potential treatment for Rett syndrome. J Transl Med. 2023 Oct 26;21(1):756.|[4]Pizcueta P, et al. Development of PPARγ Agonists for the Treatment of Neuroinflammatory and Neurodegenerative Diseases: Leriglitazone as a Promising Candidate. Int J Mol Sci. 2023 Feb 6;24(4):3201.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture)

Product Datasheet

http://file.medchemexpress.com/batch_PDF/HY-117727A/Leriglitazone-hydrochloride-DataSheet-MedChemExpress.pdf

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-117727A/Leriglitazone-hydrochloride-SDS-MedChemExpress.pdf

Clinical Information

Phase 3

CAS Number

146062-46-6

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Recombinant Lactobacillus salivarius Spermidine/putrescine import ATP-binding protein PotA (potA)
MBS1312175-01 0.02 mg (E-Coli)

Recombinant Lactobacillus salivarius Spermidine/putrescine import ATP-binding protein PotA (potA)

Ask
View Details
Recombinant Lactobacillus salivarius Spermidine/putrescine import ATP-binding protein PotA (potA)
MBS1312175-02 0.02 mg (Yeast)

Recombinant Lactobacillus salivarius Spermidine/putrescine import ATP-binding protein PotA (potA)

Ask
View Details
Recombinant Lactobacillus salivarius Spermidine/putrescine import ATP-binding protein PotA (potA)
MBS1312175-03 0.1 mg (E-Coli)

Recombinant Lactobacillus salivarius Spermidine/putrescine import ATP-binding protein PotA (potA)

Ask
View Details
Recombinant Lactobacillus salivarius Spermidine/putrescine import ATP-binding protein PotA (potA)
MBS1312175-04 0.1 mg (Yeast)

Recombinant Lactobacillus salivarius Spermidine/putrescine import ATP-binding protein PotA (potA)

Ask
View Details
Recombinant Lactobacillus salivarius Spermidine/putrescine import ATP-binding protein PotA (potA)
MBS1312175-05 0.02 mg (Baculovirus)

Recombinant Lactobacillus salivarius Spermidine/putrescine import ATP-binding protein PotA (potA)

Ask
View Details
Recombinant Lactobacillus salivarius Spermidine/putrescine import ATP-binding protein PotA (potA)
MBS1312175-06 0.02 mg (Mammalian-Cell)

Recombinant Lactobacillus salivarius Spermidine/putrescine import ATP-binding protein PotA (potA)

Ask
View Details